ApiFix
Misgav Dov
About ApiFix
ApiFix minimally invasive scoliosis correction system is aimed to treat patients suffering from Adolescent Idiopathic Scoliosis (AIS) that are classified as Lenke Type 1 or and Type 5, having with a Cobb angle from 35 to 55 degrees. Unlike the traditional scoliosis correction operation that tries attempts to fix the deformity in one aggressive and complex operation, the ApiFix system is based on a minimal surgical intervention and a correction process that spans over several months, with the aid of unique physical therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Grant (Jul 2019)
- Website: apifix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/apifix-35240 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.